High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast.
The characteristics of immunocompetent cells and their role in killing tumour cells in typical medullary carcinoma of the breast (TMC) have been investigated morphologically. Formation of high endothelial venule (HEV)-like vessels in tumour cell nests, the distribution of macrophages, T-zone histiocytes, T- and B-lymphocytes, the ratios of CD4+/CD8+, and natural killer (NK) or NK-like T-cells were examined in five cases of TMC. These results were compared with controls which consisted of three cases of ductal carcinoma with intense lymphocytic infiltration (control I) and four cases of ductal carcinoma with scanty lymphocytic infiltration (control II). An increased incidence of HEV-like vessels with migration of lymphocytes and a higher number of CD8+ lymphocytes with interleukin-2-receptor expression, as well as numerous CD57 cells, were noted in the tumour nests of TMC as compared with those of control groups. Furthermore, large granular lymphocytes, large lymphocytes invaginating tumour cells and necrotic tumour cells were observed electron microscopically. These findings indicate that infiltrating lymphocytes in TMC are activated and become effector cells that can kill the tumour cells by mechanisms similar to those of NK cells. The activities of immunocompetent cells in TMC appear to contribute to a favourable prognosis in TMC of the breast.
Tanaka
H
H
Division of Morphology, Jikei University School of Medicine, Tokyo, Japan.
Hori
M
M
Ohki
T
T
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D001402:B-Lymphocytes / Q000473:pathology / Q000648:ultrastructure; D001943:Breast Neoplasms / Q000098:blood supply* / Q000473:pathology* / Q000601:surgery / Q000648:ultrastructure; D002277:Carcinoma / Q000098:blood supply* / Q000473:pathology* / Q000601:surgery / Q000648:ultrastructure; D004730:Endothelium, Vascular / Q000473:pathology* / Q000648:ultrastructure; D005169:Factor VIII / Q000032:analysis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000473:pathology / Q000648:ultrastructure; D009336:Necrosis; D012016:Reference Values; D013601:T-Lymphocytes / Q000473:pathology / Q000648:ultrastructure; D014699:Venules / Q000473:pathology* / Q000648:ultrastructure; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D005169:Factor VIII; C067980:CD68 antigen, human; D000097382:CD68 Molecule